Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
Map-and-Ablate Technology
SyMap Medical Targets Renal Denervation With a Unique Map-and-Ablate Technology
SyMap Medical has developed a unique mapping/selective ablation RDN technology that company co-founder Jie Wang, MD, PhD, believes could provide the next major advance in the field.
March 16, 2022
Exit mobile version